ALPCO

Today’s laboratories are being asked to do more than ever — faster turnaround times, growing workloads, and increasing pressure to maintain consistent, high-quality results.

That’s why automation matters.

The KleeYa® platform is designed to help streamline daily workflows with random-access automation, continuous sample loading, and simplified operation that supports greater efficiency from sample to result.

Because modern labs need more than speed alone — they need confidence and consistency every step of the way.

Learn More: https://bit.ly/4crf9Gh

🔬 Say goodbye to batch testing.

Modern GI workflows require flexibility, efficiency, and reliable performance—and automation is helping laboratories get there.

Random-access testing allows labs to run samples as they arrive, helping reduce workflow delays while improving consistency and confidence in results.

At ALPCO, we support laboratories with automated GI testing solutions designed to streamline workflows and support reliable biomarker testing for IBD and other GI conditions.

Learn More: https://bit.ly/4tW9NZT

World IBD Day reminds us that no one lives with inflammatory bowel disease alone.
Behind every patient is a village of families, caregivers, clinicians, laboratories, and advocates working together to improve care and quality of life.

At ALPCO, we’re proud to support that network with trusted GI biomarker diagnostics, including Calprotectin and Lactoferrin assays on the KleeYa® automated platform—helping laboratories deliver timely, dependable results that support informed clinical decisions.

Today, we stand with the IBD community and everyone helping make life with IBD more manageable. 💜

💜 Raising Awareness for IBD 💜

Inflammatory Bowel Disease impacts millions of people around the world—and every diagnosis, every treatment decision, starts with better understanding.

That’s where awareness and testing matter.

Labs play a critical role in helping clinicians detect and monitor IBD, providing the insights needed to support timely, informed care.

At ALPCO, we’re proud to support this work with reliable GI biomarker testing solutions, helping labs deliver accurate, consistent results when it matters most.

The countdown is on! ⏳ We're heading to LABCON Vancouver May 8-10, and we can't wait to show you what we've been working on.

Our menu is growing with Health Canada licensed kits for Calprotectin, Lactoferrin, Pancreatic Elastase, and 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 — all running on the KleeYa® automated platform.

As we continue to grow, we're expanding our assay portfolio and transforming complex testing into streamlined, automated workflows — empowering labs to do more with less, without sacrificing throughput or performance.

📍 Find us at LABCON Vancouver ➡️ Booth #49

Drop a 👋 below or send us a message to book time with our team.

We've been working on something big—and it's finally here.

8 NEW automated CLIA assays for Therapeutic Drug Monitoring measuring
both drug levels and total anti-drug antibodies (ADAs) on the KleeYa® platform.

New TDM Drug Level & Total ADA Assays:
Adalimumab | Infliximab | Ustekinumab | Vedolizumab

Why it Matters:
Automated Workflows = Less Hands-on Time
CLIA-Based = High Sensitivity & Specificity
Drug Levels + ADAs = The Full Picture

KleeYa®—Fully Automated Platform
Engineered for accuracy. Designed for efficiency. Built for every lab, everywhere.

🔗 See the full lineup: https://www.alpco.com/instruments/flash-chemiluminescence.html

ICYMI: During our own Krista Meserve, PhD presented exciting research on a new approach to RPR testing.

At ALPCO, we're working to modernize syphilis testing with a fully automated immunoassay designed to remove subjectivity from nontreponemal testing and deliver more consistent, objective results.

Thank you to everyone who stopped by Poster P5264, asked thoughtful questions, and shared insights with our team.

See the poster here: https://bit.ly/48jxnqx

👀 What if we told you RPR reading doesn't have to be subjective anymore?

We've been working on something that could change how labs diagnose syphilis — and we're presenting it TODAY at .

🔬 We’ve developed a fully automated immunoassay that removes the guesswork from nontreponemal testing, delivering consistent, objective results that support confidence and modern diagnostic workflows. Come see how.

📌 Poster P5264 | Hall B3
🗓 Tuesday, April 21 | 12:00–1:30 PM

Challenge us, ask questions. We'll be there. 👋

April is IBS Awareness Month 💙

Irritable Bowel Syndrome (IBS) affects millions of people worldwide, highlighting the importance of awareness, education, and access to reliable diagnostic tools.

At ALPCO, we’re proud to support laboratories with solutions designed to deliver accurate, consistent results—helping clinicians make more informed decisions.

Better testing supports better care.